1 I 2 Program Frequently Asked Questions What is the Genome BC Industry Innovation (I 2 ) Program? The I 2 Program offers repayable growth capital to businesses (with less than 500 employees), commercializing innovative life science technology-based products, processes or services. The I 2 Program is a concrete step towards bridging the gap between innovation and commercialization in the BC bioeconomy. Life sciences includes any technologies that address human health issues as well as any biological challenges faced in the key economic sectors of Agrifood, Energy, Mining, Environment, Fisheries and Aquaculture, and Forestry. Funding through the I 2 Program is non-dilutive, repayable and has success oriented service charges. It is allocated to promising technologies at the early stages of commercial development. The I 2 Program aims to provide risk capital that is concurrently matched by other public or private funding sources. Is the I 2 Program a provincial program? The I 2 Program is a Genome BC initiative that is available to small-and medium-sized enterprises (SMEs) with operating facilities in BC. Is the I 2 Program a permanent initiative? The I 2 Program is intended to be an ongoing initiative of Genome BC. What is a small and medium-sized enterprise (SME)? A small- and medium-sized enterprise is defined by Industry Canada as a for-profit entity that has less than five hundred employees. What are the objectives of the I 2 Program? The I 2 Program aims to: Commercialize innovative life science technology-based products, processes, and services; Stimulate greater private sector investments in commercialization activities in the bioeconomy; Increase the number of jobs for highly qualified personnel in BC; Enable company growth. Why is Genome BC funding businesses? Through the I 2 Program, Genome BC is addressing a gap in private sector funding of the bioeconomy and the need to drive innovation, commercial success and economic prosperity in BC. More support is needed beyond the Research and Development phase to bring ideas through to commercially useful innovation. Attracting early-stage capital for life science technology commercialization has been identified as a key challenge for SMEs in BC. By helping businesses access financing and private investment, as well as supporting technology commercialization, we are harnessing the entrepreneurial spirit of this province, nurturing great ideas and strengthening BC s economy. Who will benefit from the initiative? The I 2 Program will help create an environment where businesses can thrive and compete in today's marketplace by exploiting life-science based technologies, ultimately strengthening BC s economy.
2 As an investor, how can I benefit from I 2 Program? Investing in technology commercialization is intended to encourage partnerships between SMEs and the investor community. While there is no funding to support angels or venture capital investors directly, investors working with businesses active in BC will be able to leverage their investments in companies that receive funding from the I 2 Program. Eligibility Who is eligible for funding? The I 2 Program s repayable financing will be available to SMEs that meet the following mandatory criteria: SMEs (less than 500 employees) that are incorporated to do business in Canada and have operating facilities in British Columbia; Have a viable plan to successfully commercialize (i.e., generate significant revenues from sales and/or licensing activities) an innovative, life science technology-driven, new or improved product, process or service within four years of initial I 2 Program disbursement; Ownership or contractually binding access to the intellectual property rights to carry out the proposed technology development and to commercially exploit the results of the project; Have provided a current business plan that details the investment opportunity and recent financial statements; Have identified, at the time of application, matching funding from all other sources, including government and non-government as well as existing cash resources (these sources of funding must represent at least 100 percent of the proposed I 2 Program financing and be secured by the closing date of the I 2 funding). Are there specific sectors that are being targeted by the I 2 Program? The I 2 Program will target the following sectors where the exploitation of life science based technologies will strongly benefit the province of BC in Agriculture, Energy and Mining, Clean tech and Environment, Fisheries and Aquaculture, Forestry, and Health. How much funding is available? The I 2 Program launched in 2015 with an initial $6.8 million pool of capital and was further augmented with another $4 million in Eligible SMEs may request $100,000 to $1 million per company (and affiliates) to commercialize the development of their technology-based products, processes and services over a maximum five-year period. Only a limited number of exceptional SME s are likely to receive a full $1 million in I 2 Program support. How many companies will Genome BC fund under I 2 Program? It is expected that the requests for funding may exceed the amount of funding available. The total number of companies funded will depend on the amounts requested by the successful applicants. What is the likelihood that I will receive funding? Only applications demonstrating the highest merit that fit with I 2 Program objectives, will be considered for funding. Many good projects and businesses may not receive support from the I 2 Program. What are the attributes of a strong proposal? All eligible applications will be evaluated on their ability to achieve the objectives of the I 2 Program and on their strengths in the areas of management, technology readiness, market potential, financial capacity and economic benefits.
3 Strong projects will demonstrate: A complete and viable business plan; Qualified, experienced and complete management team; Technology readiness for commercialization, strong value proposition and necessary IP; Market potential (i.e., strategic or supply chain partnerships in place, potential customers/investors identified, etc.); Financial capacity to execute (i.e., non-genome BC funding in place, existing revenues from other product lines, etc.) and ability to repay; and, Measurable economic benefits to BC. What kinds of activities are supported by I 2 Program? I 2 Program supports activities in a variety of sectors; however, the funding is intended to support activities to validate commercial proof of concept and to commercially launch a product, process or service. Examples of supported commercialization activities include, but are not limited to: Introduction of a new product, process or service to new or existing markets; Improvement of products, processes or services; Technology development/acceleration; Product certifications; Pilot projects (first user) and technology demonstration projects; Validation of market potential and end-user acceptance; and Support for marketing, human resources development, productivity, and process or quality improvement directly related to the commercialization of new opportunities. What costs are eligible? The I 2 Program is providing repayable growth capital to SME s where these proceeds are to be allocated to all necessary activities for the development and commercialization of promising life science-based technologies that have the potential to provide benefits to BC. The company must also commit to using BC based suppliers of goods and services for the technology development program where feasible and market competitive, and to ensure that all or substantially all of its employees or contractors who work on the technology development program are residents of BC if feasible. Genome BC reserves the right to make the final determination on the value of its support and to exclude expenditures deemed to be ineligible or outside the scope of the I 2 Program. What types of activities and costs are ineligible? I 2 Program will not support costs that can be typically financed through conventional sources, such as land and buildings. Other non-eligible costs include: losses, amortization or depreciation of assets, fines, and penalties. Additionally, costs associated with certain activities, such as basic or applied research and lobbying, will not be supported. Is there a limit to the number of times that I may apply? There is not a limit to the number of applications a company may submit. Does my business have to be incorporated for at least a year? No. The eligibility requirements are that you must be incorporated at the time of application to the I 2 Program.
4 What if the parent and subsidiary combined have more than 500 FTEs would the subsidiary (with less than 500) be eligible? No. If both the parent and subsidiary have more than 500 FTEs, then Genome BC would not consider the subsidiary as eligible under I 2 Program. On a related note should there be a controlling interest by an investment firm, such as a venture capitalist, only the FTE count for the company applying will be considered for eligibility purposes and not the FTE count of the venture capitalist. If there is a company from outside BC that wanted to start a company in BC could they apply? Yes. However, the company must establish tangible operating facilities in BC (with personnel) at the outset of their I 2 funding. Can money already invested in the company be considered part/all of the matching funding? A company can use its existing cash or investments only if applied to new activities and costs i.e. costs that are incurred after the I 2 Program start date. This is essentially the net working capital at closing. (i.e. current assets less current liabilities.) What do you require as proof or evidence of identified matching funding at the time of application? Is a letter of intent sufficient? Are projected revenues from future sales acceptable? Written proof, confirmed or conditional upon other sources of funding, will be considered acceptable. Examples of written proof include binding, term sheets, funding agreements, or current bank statements detailing existing cash balances or the unused portion of lines of credit. These documents will be reviewed in greater detail as part of Genome BC s due diligence. Genome BC does not consider the following as sources of confirmed funding: Forecasted revenues from future activities; non-binding letters of intent; Commitments to raise equity; Commitments to obtain future bank financing; and Forecast Scientific Research & Experimental Design (SR&ED) credits. (however, accrued SR&ED refunds at closing will be an eligible source of funding if the company has a track record of receiving SR&ED refunds.) Can the non-genome BC sources of funding be changed after the initial application? Any changes to funding sources would have to be considered on a case by case basis. Generally speaking as long as the SME continues to be capitalized sufficiently (meeting mandatory eligibility requirements) Genome BC will continue to assess the investment opportunity. If a SME's commercialization plan is to undertake a series of activities that will enable it to license its product to a large company, within four years, for a fee (revenue) is it eligible for the I 2 Program? Yes. Provided that the SME has the necessary IP rights to carry out the proposed technology development and it is feasible to commercially exploit the results within 4 years, the company would be eligible for financing from the I 2 Program. Commercially exploit includes out-licensing activities. What is a viable business plan? It is recommended that you consult the Canada Business Network to access a variety of business plan
5 tools from the BDC and Canada's major banks to ensure that your plan is complete and contains sufficient information to be assessed as a viable business plan. Another source for business plan tips and templates is the MARS Discovery District (incubator) Generally, a business plan should include: A description of the business and new product, process, or service being commercialized (please include a description of intellectual property and freedom to operate); An analysis of the marketplace (including industry factors, competition, and customers); A detailed sales and marketing strategy; A description of the management team and corporate governance structure; Operating/execution plan for commercializing the new product; Forecasted income statements, cash flow for the duration of the company s development work and up to an additional two years (pro-forma statements) Application How do I apply for funding through the I 2 Program? Applicants are strongly encouraged to submit an Executive Summary (max. 5 pages) of their business plan highlighting: The company, team and BC-based activity The technology/service and value proposition The market opportunity The commercialization plan The financial requirements, prospective co-funders and risks involved Submissions should be ed to: Pat Brady, Director, Industry Innovation Programs Only those applicants with the strongest applications will be invited to submit their full business plan for further consideration. What are the application deadlines? Applications are accepted at any time. However, the Board of Directors of Genome BC will make the ultimate investment decisions. Board meetings and I 2 Program investment decisions are made approximately quarterly. Can I review my application with you before submitting it? Genome BC staff will not be reviewing nor assisting applicants to prepare their first submission of an Executive Summary prior to its submission. However, we will be available to discuss your company s eligibility for I 2 funding before your submission. How do I know if my application was received? All applicants will receive an acknowledgement notification, confirming that their application has been received.
6 How will I 2 Program investment opportunities be assessed and approved? All proposals will be assessed and approved in five stages: Stage 1 The first stage will consist of an initial assessment of the Executive Summary to determine if the SME s business plan meets the mandatory criteria under the I2 Program. During this stage, applicants will also be assessed to determine how strongly they align with the goals of the I2 Program, whether they demonstrate a high likelihood of success and tangible benefits to BC and whether they will have non- Genome BC matching funding secured by expected closing. Stage 2 Assuming a positive assessment in Stage 1, Genome BC will invite the company to submit a full business plan and/or other form of presentation to Genome BC for the second stage of assessment. Stage 3 Assuming support of Genome BC in Stage 2, a formal due diligence process is conducted to determine the likelihood of commercialization and clearly establishing a pathway to success. A confidential third party review of the company s technology, IP and/or market will often be performed at this time. If significant gaps are identified during the due diligence process, funds will not be advanced but Genome BC will endeavour to point the company toward resources and partners that are able to help remedy the deficiencies. Stage 4. If a company is successful at Stage 3, then the next stage is to negotiate and reach agreement on a term sheet detailing: Key financial terms Repayment terms Identification of commercialization milestones and tranche advancement requirements, if any Closing conditions, co-funding and target dates Information rights Stage 5. Upon completion of due diligence and negotiating the term sheet, the company will be asked to formally present to Genome BC in the fifth and final stage of the review process. The Board of Directors of Genome BC will make the ultimate investment decision. Board meetings and investment decisions are made approximately quarterly. Genome BC will seek input from the I 2 Advisory Council comprised of experienced businesspersons from the field of technology commercialization, entrepreneurs, and others in related fields that will provide strategic advice on the suite of investments under consideration by Genome BC. Members of this Committee are required to sign a confidentiality agreement and a conflict of interest agreement with Genome BC. Are there any fees to apply or to go through the assessment and due diligence? There are no fees associated with the application or assessment process. However, an applicant can expect that during the detailed due diligence period, they may be required to fund the costs of Genome BC obtaining third party expert opinions regardless of whether or not the I 2 Program makes an investment. Genome BC will obtain prior approval from the applicant before incurring these expenses.
7 Can you assure me that any confidential commercial information I submit will be protected? Assessment of the applications will be undertaken by Genome BC. All submitted information will be kept in strict confidence. Confidential commercial information will not be shared without the applicant's consent. Genome BC will execute a NDA. Will Genome BC ask for missing information if I am not successful, will I be informed why so I can address any weaknesses in my application for a future submission? Genome BC staff may follow-up with clarification questions and may ask for the provision of new information. Genome BC will try to provide individualized support for any applicant. However, applicants must clearly demonstrate the ability to bring innovative ideas from the later stages of research and development to a commercialized product, process or service. Investment (Loan) How are disbursements made? If you are successful in obtaining I 2 Program funding for your company, Genome BC will normally provide the repayable funding in an upfront disbursement at closing plus additional tranches triggered by the achievement of pre-determined milestones. Milestone events must be significant in nature for the development and commercialization of the technology. Milestone events must be described in a clear and objective fashion to avoid ambiguity whether they have been achieved or not. Ideally they are measureable. Potential funding recipients are expected to have secured all non-genome BC matching financing (minimum 100%) before closing of the I 2 Program investment. What kind of reporting is required during the funding period? All successful applicants will sign a standard Loan Agreement with Genome BC. The Agreement outlines the obligations of the funding recipient, including Genome BC s information rights which will require, at a minimum, quarterly reports including company progress reports, financial statements, budget variance reports and pro forma cash flows. In most circumstances, Genome BC will require Board Observer rights. Genome BC retains visitation rights and the right to audit the loan recipient s business during the loan repayment period and while any royalty payment obligations are outstanding. When must technology commercialization projects be completed? The duration of the commercialization project may vary, ranging from a few months to multiple years; however, project plans must demonstrate the ability to fully commercialize the technology within four years of the first disbursement from the I 2 Program. What type of loan are you providing in this initiative? Through this initiative Genome BC will provide 'repayable funding essentially an interest- bearing loan that will be secured with a General Security Agreement. What is the I 2 Program loan security? Genome BC loans will be secured with a General Security Agreement (GSA) granting an interest in all of the company s and any subsidiary s present and after acquired property. The GSA includes a double negative pledge on all intellectual property.
8 What is the I 2 Program loan interest rate? I Program loans are interest-bearing. Interest is calculated from the time of disbursement, compounded annually, and accrued until the repayment schedule is launched. Interest will be at a below market rate, usually RBC Prime plus %. Interest penalties will be incurred if there are loan repayment defaults. How long do funding recipients have to repay the I 2 Program s loan? Funding recipients will be required to repay the I 2 Program loan principal and any accrued interest starting from the earliest of the following typical Commercialization Triggers : four years from the first disbursement of funds from the I 2 Program ; the date that the commercialized technology achieves pre-negotiated revenue and/or sales volume targets; target revenues from licensing the technology; the company achieves a significant financial milestone such as an IPO or change of ownership control. Recipients will be required to make quarterly repayments of the principal and accrued interest amortized over the two years following the occurrence of a Commercialization Trigger. Therefore, the funding recipient will have a maximum of six years to repay Genome BC s total principal and interest amount from its initial disbursement. There is no prepayment penalty. I 2 Program loans also carry a Royalty obligation. What is the I 2 Program royalty obligation? A royalty obligation is part of the I 2 Program agreement. The royalty agreement is structured so that Genome BC receives a low, single-digit annual royalty payment if the technology financed results in significant commercialization revenue. The royalty payments usually commence in the year of the Commercialization Trigger. The cumulative royalty payments are capped at 2X the amount of the I 2 Program loan principal. Are there any cash fees to close (set up) the I 2 Program loan facility? There are no cash fees associated with the application process nor the execution of the I 2 Program loan transaction. However, the company will pay for all legal expenses incurred by the Genome BC to document and execute the I 2 Program loan transaction. Are there any non-cash fees to close (set up) the I 2 Program loan facility? At closing, Genome BC will receive a Warrant - the right to purchase that number of shares of preferred or common stock of the company equal to 2% of the total I 2 Program loan divided by the Exercise Price. The Exercise Price will be equal to the per share price of the most recent equity round (common or preferred). The Warrant will have a ten year maturity and standard anti-dilution protection. Do you offer grants or subsidies under the I 2 program? No, grants and subsidies are not provided under the I 2 Program. I 2 Program recipients will receive funding that they are responsible to repay (a repayable contribution). What happens if the loan isn't repaid? Genome BC expects that I 2 funding will be repaid. If funds are not repaid, Genome BC will take appropriate measures to collect the amount owing from this loan default condition. The company (borrower) shall also be in default upon the occurrence of a material impairment of the prospect of repayment of the I 2 Program loan.
9 What control does Genome BC want over my business if I accept this loan? Genome BC will not take a role in the operation of your business. Further, Genome BC will not be taking any equity positions in businesses that receive funding under this program other than Warrants If I am successful, can I pay back the loan early? Is there a penalty? There is no penalty for early repayment. Repayment of the loan shall not release the company from its royalty obligations as set out in the I 2 Program royalty obligation. In fact, early repayment may trigger reductions in the Royalty Cap. Will you provide loan guarantees? No, loan guarantees will not be offered under the I 2 Program, i.e., the intention is NOT to provide a guarantee to another lender. Will you offer a line of credit for growing businesses? Applicants will not be offered a line of credit under the I 2 Program. Do you provide asset-based financing? Genome BC will not provide repayable financing based solely upon the assets you have in your business. We base our decisions on a variety of factors that will include: market potential, management strength, technology readiness and financial capacity. Will you provide financing based upon future projections for a newly invented technological product? Yes, an applicant does not have to have existing revenues to be eligible to receive I 2 Program funding. It is required that the business be incorporated and have secured all other sources of non-genome BC matching funding at the time of disbursement. What are the tax implications of an I 2 Program repayable loan? It is recommended that you seek independent professional tax and accounting advice to assess and determine the full tax implications of your company being in receipt of an I 2 Program repayable loan. Are existing or potential tax credits considered matching funding? If your company has an existing refundable tax credit receivable with the Scientific Research and Experimental Development (SR&ED) program and a valid track record for the receipt of past SR&ED tax credit claims, then 75% of the existing SR&ED receivable tax credit will be an eligible amount for the purposes of defining matching funding for I 2 Program investments. However, future unaccrued SR&ED tax credits will not be considered matching funding. It is also recommended that you seek independent professional tax and accounting advice to assess and determine what costs and activities of your activities might be eligible for federal or provincial tax credits. Who can I contact for more information? Contact Pat Brady, Director, Industry Innovation Programs
INNOVATION SUPERCLUSTERS Information Session INTRODUCTION Budget 2017 made $950 million available over five years, starting in 2017-18, to support a small number of business-led innovation superclusters
Startup SG Tech FAQ A. Eligibility 1. What are the eligibility criteria under Startup SG Tech? The Startup SG Tech is primarily aimed at startups that are registered or incorporated in Singapore and physically
Genomic Applications Partnership Program (GAPP) Investment strategy and exceptions to Genome Canada s Guidelines for Funding December 1, 2017 1 Contents 1. GAPP Overview... 3 2. GAPP Objectives... 4 3.
[DOCUMENT TITLE] [Document subtitle] PROGRAM OVERVIEW The Community and Regional Economic Support (CARES) program funds initiatives of Alberta municipalities, communities and regions that enhance local
PROGRAM OVERVIEW The Community and Regional Economic Support (CARES) program is a two-year initiative under the Alberta Jobs Plan that runs from 2016 to 2018. The CARES program funds initiatives of Alberta
CTNext Higher Education Entrepreneurship and Innovation Fund Program Guidelines 1. General Information CTNext Mission CTNext, a wholly owned subsidiary of Connecticut Innovations (CI), aims to foster entrepreneurship
LEAP For Industry Transforming Technologies -OPEN CALL FOR PROPOSALS- Looking to move beyond your competition, break into new markets, or transform your industry through the development and commercialization
QIKIQTANI INUIT ASSOCIATION AND KAKIVAK ASSOCIATION PROGRAM GUIDELINES BUSINESS CAPACITY AND START UP FUND 1 PART ONE: BCSF FRAMEWORK LIST OF ACRONYMS BCSF - Business Capacity and Start-up Fund BIMC Baffinland
PROGRAM GUIDE: THE CLEAN TECHNOLOGY COMMERCIALIZATION PROGRAM Part of the Climate Change Innovation and Technology Framework PROGRAM OVERVIEW Background In December 2017, the Government of Alberta (GOA)
PROGRAM GUIDE: THE CLEAN TECHNOLOGY BUSINESS INNOVATION VOUCHER PROGRAM Part of the Climate Change Innovation and Technology Framework PROGRAM OVERVIEW Background In December 2017, the Government of Alberta
Funding Programs Guide Aquaculture Sector December 2017 A Commitment to Grow Aquaculture As part of The Way Forward, the Newfoundland Aquaculture Industry Association and the Government of Newfoundland
Summary Introduction The Province offers a significant number of programs that provide direct financial assistance to businesses. Direct financial assistance can be provided by way of Government grants,
Opportunity Finance Network Guide to CDFI Program (Financial Assistance and Technical Assistance) FY2015 v.3 October 23, 2014 This guide reflects an analysis of the FY2015 Notice of Funds Available (NOFA),
1 CONTENTS Introduction 2 Programme Benefits 2 Contact the Programme Team 2 Eligibility 2 Companies 2 Research Institutes 2 Application Process 3 Process Outline 3 Who Applies? 4 Application Forms 4 Phase
Food Innovation Australia Limited (FIAL) Enterprise Solution Centre Programme Frequently Asked Questions INTRODUCTION FIAL s Enterprise Solution Centre Programme (ESCP) connects businesses with researchers
CLEAN TECHNOLOGY DEMONSTRATION PROGRAM PROGRAM OVERVIEW PROGRAM GUIDELINES The BLOOM Clean Technology Demonstration Program (the Program ) is a merit-based, cost-share program that is supporting Ontario
GOING GLOBAL INNOVATION (GGI) APPLICANT GUIDE This version of the Guide expires on March 31, 2018. Definitions Angel Investors Angel investors are high-net-worth individuals/networks, often entrepreneurs
Agenda I. Types of non-dilutive Funding II. Mandates of Funding Programs III. When to Access Programs IV. Pre-emptive VS retroactive V. The SR&ED Program VI. How Funding Programs Stack boast.ai 1 I. Types
Entrepreneur Support Network Partners Capital for Hiring MaRS Embark Funding $20,000 (including HST) 12.5% requested ($2,500 cash) Funding to hire a young professional (22-29) in a business role full-time.
Post-Secondary Clean Energy Partnerships 2016 Program Guide Table of Contents 1. Program Overview... 2 2 Eligibility... 5 3 Application Process... 6 4 How your LOI submission will be Evaluated... 8 5 Approval
ENTERPRISE LEIDEN FUND Enterprise Leiden Fund provides a loan to ambitious and enterprising people. The funding enables you to focus on enhancing your entrepreneurial skills and developing the business
IAS Standard 20 Accounting for Government Grants and Disclosure of Government Assistance In April 2001 the International Accounting Standards Board adopted IAS 20 Accounting for Government Grants and Disclosure
Introduction Procedure for Setting up and Managing a Spin-out Company 1. Northumbria University s strategic plans for Business and Engagement and Research actively support and encourage the commercialisation
INNOVATION SUPERCLUSTERS APPLICANT GUIDE 1 To obtain a copy of this publication or an alternate format (Braille, large print, etc.), please contact: Permission to Reproduce Except as otherwise specifically
REQUEST FOR PROPOSALS FOR MULTI-UNIT RESIDENTIAL PROJECTS SERVING POPULATIONS WITH SPECIAL NEEDS New Hampshire Housing Finance Authority (the Authority ) is seeking applications for financing from qualified
Sri Lanka Accounting Standard LKAS 20 Accounting for Government Grants and Disclosure of Government Assistance CONTENTS paragraphs SRI LANKA ACCOUNTING STANDARD LKAS 20 ACCOUNTING FOR GOVERNMENT GRANTS
CITY OF LANCASTER REVITALIZATION AND IMPROVEMENT ZONE AUTHORITY Guidelines for Obtaining Financing for Projects in the City of Lancaster s City Revitalization and Improvement Zone Purposes of These Guidelines
Northern Community Economic Development Program Guide UPDATED - 2019 Northern Community Economic Development Program Guide 2019 Table of Contents Purpose 1 Board Vision: Our Economy 1 Goal: Enhanced Economic
LOW-CARBON INNOVATION FUND (LCIF) 2017-18 Program Guidelines What is the Low-Carbon Innovation Fund? The Low-Carbon Innovation Fund (LCIF) is a discretionary, non-entitlement granting program administered
General block exemption Regulation (Reg. 651/2014) working document Aid for research and development and innovation First the general conditions of application of the GBER should be checked (12 conditions
Canadian Grants: A Crash Course in Non-Dilutive Funding Presented by Erik Ashdown Director, Business Development Boast Capital boast.ai Agenda I. Types of non-dilutive Funding II. Mandates of Funding Programs
Venture Development Fund Request for Proposals Summary The State of Oregon, through legislation encouraging philanthropic donations targeted to support the commercialization of research at Oregon s Universities,
Sri Lanka Accounting Standard-LKAS 20 Accounting for Government Grants and Disclosure of Government Assistance -609- Accounting -610- Definitions 3 The following terms are used in this Standard with the
International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance This version includes amendments resulting from IFRSs issued up to 31 December 2010. IAS 20
HANDBOOK FOR THE INDIGENOUS ECONOMIC DEVELOPMENT FUND January 2018 (WHAT YOU NEED TO KNOW BEFORE YOU APPLY) Before completing an Indigenous Economic Development Fund (IEDF) application, please read the
MINISTRY OF SCIENCE, TECHNOLOGY AND INNOVATION, MALAYSIA TECHNOFUND GUIDELINES FOR APPLICANTS (Revised January 2016) Pre Commercialization Fund (TechnoFund) Secretariat Fund Division Ministry of Science,
CITY OF ELKO NEW MARKET, MINNESOTA BUSINESS ASSISTANCE POLICY Adopted July 26, 2012 I. PURPOSE The purpose of this policy is to provide guidance for the City of Elko New Market (the City) in its provision
Kentucky New Energy Ventures Scope & Goals 1. Grow alternative fuel and renewable energy companies in Kentucky to drive statewide economic growth; 2. Stimulate private investment in Kentucky-based alternative
6 November 2018 Global Tax Alert New Zealand introduces new research and development tax incentive NEW! EY Tax News Update: Global Edition EY s new Tax News Update: Global Edition is a free, personalized
LOW-CARBON INNOVATION FUND (LCIF) 2017-18 Program Guidelines What is the Low-Carbon Innovation Fund? The Low-Carbon Innovation Fund (LCIF) is a discretionary, non-entitlement granting program administered
170 Accounting Standard (AS) 12 (issued 1991) Accounting for Government Grants Contents INTRODUCTION Paragraphs 1-3 Definitions 3 EXPLANATION 4-12 Accounting Treatment of Government Grants 5-11 Capital
The National Innovation Fund - an instrument for promotion of innovative SMEs Bulgarian SME Promotion Agency 1 1. Introduction In August 2004 the Council of Ministers adopted the Innovation Strategy of
Canada Music Fund Music Entrepreneur Component Aid to Canadian Music Publishing Firms Application Guide 2016-2017 Her Majesty the Queen in Right of Canada, represented by the Minister of Public Works and
175 Accounting Standard (AS) 12 (issued 1991) Accounting for Government Grants Contents INTRODUCTION Paragraphs 1-3 Definitions 3 EXPLANATION 4-12 Accounting Treatment of Government Grants 5-11 Capital
OMDC Film Fund Production Guidelines, including Diversity Enhancement Program Deadlines: Cycle 1 2018/19: April 11, 2018 (by 5:00pm) Cycle 2 2018/19: October 2, 2018 (by 5:00 pm) Contents 1. Introduction
Canadian Agricultural Automation Cluster: Call for Proposals Deadline: 5pm EST Tuesday November 14, 2017 The Initiative: Vineland Research and Innovation Centre (Vineland) is currently developing a large-scale
18 September 2017 Global Tax Alert News from Americas Tax Center Canada accepting applications for the new Strategic Innovation Fund EY Global Tax Alert Library The EY Americas Tax Center brings together
Summary 1. Subaward Definitions A. Subaward B. Subrecipient University of San Francisco Office of Contracts and Grants Subaward Policy and Procedures C. Office of Contracts and Grants (OCG) 2. Distinguishing
Pennsylvania First Program Guidelines September 2011 > ready > set > succeed newpa.com Table of Contents Section I Statement of Purpose...............................................1 Section II Eligibility..........................................................1
Canada Music Fund Music Entrepreneur Component Aid to Canadian Music Industry National Service Organizations Application Guide 2015-2016 Her Majesty the Queen in Right of Canada, represented by the Minister
Incentive Guidelines Research and Development - Tax Credits INDUSTRIAL RESEARCH PROJECTS; EXPERIMENTAL DEVELOPMENT PROJECTS; INTELLECTUAL PROPERTY RIGHTS COSTS (FOR SMALL AND MEDIUM-SIZED ENTERPRISES).
International Energy Demonstration Fund Program Guidelines Program Overview Ontario is internationally recognized for its energy sector expertise, positioning it well to participate in competitive global
FIPN COMPLEMENTARY DETAILS FONDS D INITIATIVES DU PLAN NORD (FIPN) Next call for projects: September 2017 FONDS D INITIATIVES DU PLAN NORD (FIPN) Objectives The FIPN supports and promotes projects that:
City of Battle Lake, Minnesota Business Subsidy Criteria Adopted February 24, 2015 Table of Contents 1. 2. 3. 4. 5. Purpose & Authority Public Purpose Criteria Valuation of a Business Subsidy Evaluation
R&D TAX INCENTIVE What is the Research & Development (R&D) Tax Incentive? The R&D Tax Incentive program is the Australian Government s principle measure to enhance and increase the amount of research and
GUIDANCE DOCUMENT 4RE003-000 Resource Efficiency Waste Prevention Implementation Fund 1. Background and Aims Resource Efficient Scotland is a programme delivered by Zero Waste Scotland which helps organisations
INVEST. TRADE. PROSPER. Financial Incentives that Keep on Giving: The Case for Vancouver Calgary Saskatoon Winnipeg Waterloo Region London Québec City Montréal Ottawa Toronto Halifax Financial Incentives
New York State COMMUNITY DEVELOPMENT BLOCK GRANT PROGRAM Microenterprise Assistance PROGRAM GUIDELINES OFFICE OF COMMUNITY RENEWAL ANDREW M. CUOMO, GOVERNOR RUTHANNE VISNAUSKAS, COMMISSIONER TABLE OF CONTENTS
GUIDELINES FOR OPERATION AND IMPLEMENTATION OF ONE NORTH CAROLINA FUND GRANT PROGRAM ( the Program ) The following Guidelines for the Program are submitted for publication and comment by the Department
Request for Proposals to Identifying Gaps in Local Food Product Supply for Ontario Agri-Product Processors Request Date: April 1, 2018 Deadline: May 15, 2018, 12:00pm EST This is a Request for Proposals
Advance Queensland Ignite Ideas Fund - Guidelines for Applicants Introduction The Ignite Ideas Fund aims to support small to medium Queensland businesses to scale-up market ready, innovative product, process
ONTARIO SENIORS SECRETARIAT SENIORS COMMUNITY GRANT PROGRAM GUIDELINES 2014-2015 SENIORS COMMUNITY GRANT PROGRAM 2014-2015 GUIDELINES TABLE OF CONTENTS 1. HIGHLIGHTS... 3 BACKGROUND... 3 2014-15 FUNDING...
Farm Energy and Agri-Processing Program Terms and Conditions 1. Purpose The Farm Energy and Agri-Processing Program shares costs with the agriculture and agriprocessing sector on energy efficiency investments.
WOMEN ENTREPRENEURSHIP FUND APPLICATION GUIDE TABLE OF CONTENTS WOMEN ENTREPRENEURSHIP CONTRIBUTION FUND Section A General Information 1. Introduction 2. About the Women Entrepreneurship Fund 3. Application
Indian Accounting Standard (Ind AS) 20 Accounting for Government Grants and Disclosure of Government Assistance (This Indian Accounting Standard includes paragraphs set in bold type and plain type, which
Ontario Centres of Excellence (OCE) and Sustainable Development Technology Canada (SDTC) July 2016 Joint Call for Expressions of Interest for Canadian Small and Medium Enterprises for Greenhouse Gas Reduction
Fast Track to Innovation Pilot (2015) Call opening: January 6, 2015 First Cut-off Date: April 29, 2015 Frequently Asked Questions Official European Commission document December 2014 Contents A. Eligibility
New York State COMMUNITY DEVELOPMENT BLOCK GRANT PROGRAM Microenterprise Assistance FREQUENTLY ASKED QUESTIONS OFFICE OF COMMUNITY RENEWAL ANDREW M. CUOMO, GOVERNOR RUTHANNE VISNAUSKAS, COMMISSIONER MICROENTERPRISE
Processing Research Partners Program Objectives The primary objective of the program is to stimulate and support the undertaking of high quality, scientifically valid, short-term (normally 3 years or less)
2018 Guidelines Community Grant Program Grant applications are due Friday, October 13, 2017 by 4:30 PM 2 P a g e TABLE OF CONTENTS PURPOSE...... 4 FUNDING CATEGORIES...... 5 ELIGIBILITY...... 6 INELIGIBILITY......
2014 to 2020 European Structural and Investment Funds Growth Programme Call for Proposals European Regional Development Fund Priority Axis 1: Promoting Research and Innovation Managing Authority: Fund:
Empire State Development New York s Chief Economic Development Agency EMPIRE STATE DEVELOPMENT PROGRAMS ESD GRANT FUNDS EXCELSIOR JOBS PROGRAM JOB DEVELOPMENT AUTHORITY LOANS ESD Grant Funds Program Objectives:
Life Sciences Tax Incentive Program Solicitation No. 2017 TAX-01 Program Manager: Cheryl Sadeli, Vice President of Finance Questions: Taxprogram@masslifesciences.com Solicitation Issued: December 4, 2017
Program Guidelines 2017 18 Accelerating Food Innovation in Alberta: Application of Research or Technology for New Product Development 2 Program Guidelines 1.1 Purpose The 2017 18 Accelerating Food Innovation
Enhanced Phase 0 Grant Program Announcement & Call for Proposals Background The Oregon Innovation Council (Oregon InC) seeks to support the creation and growth of companies with high-growth potential emerging
rian Regional Innovation Acceleration Network The network of venture development organizations driving America s economy SMARTER. FASTER. FORWARD. Venture Development Organization Profile July 2011 TECHCOLUMBUS
ENVIRONMENTAL STEWARDSHIP AND CLIMATE CHANGE PRODUCER PROGRAM TERMS AND CONDITIONS 1.0 PURPOSE The Environmental Stewardship and Climate Change Producer Program will support Active Producers with the implementation